TYPE 2 DIABETES MELLITUS AND HEPATOCELLULAR CARCINOMA ARE RISK FACTORS FOR HEPATIC ENCEPHALOPATHY IN PATIENTS WITH END-STAGE LIVER DISEASE

被引：0
|
作者：
Sundaram, Vinay [1 ]
Ganesh, Swaytha [2 ]
Behari, Jaideep [1 ]
机构：
[1] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1216
引用
收藏
页码：911A / 912A
页数：2
相关论文
共 50 条
  • [31] Liver resection for hepatocellular carcinoma in patients with end-stage renal failure
    Cheng, SB
    Wu, CC
    Shu, KH
    Ho, WL
    Chen, JT
    Yeh, DC
    Liu, TJ
    P'eng, FK
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 78 (04) : 241 - 246
  • [32] Association of Type 2 Diabetes and Hepatic Encephalopathy in Chronic Liver Disease Patients
    Usmani, Mohsin A.
    Rahman, Attiya S.
    Jamal, Qaiser
    Siddiqui, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [33] May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?
    Lucidi, Cristina
    Lattanzi, Barbara
    Riggio, Oliviero
    Merli, Manuela
    JOURNAL OF HEPATOLOGY, 2018, 68 (06) : 1324 - 1325
  • [34] Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
    Swee H. Teh
    John Christein
    John Donohue
    Florencia Que
    Michael Kendrick
    Michael Farnell
    Stephen Cha
    Patrick Kamath
    Raymond Kim
    David M. Nagorney
    Journal of Gastrointestinal Surgery, 2005, 9 : 1207 - 1215
  • [35] Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
    Teh, SH
    Christein, J
    Donohue, J
    Que, F
    Kendrick, M
    Farnell, M
    Cha, S
    Kamath, P
    Kim, R
    Nagorney, DM
    JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (09) : 1207 - 1215
  • [36] Significance of Incorporation of Model for End-Stage Liver Disease Score with TNM Staging in Patients with Hepatocellular Carcinoma Undergoing Hepatic Resection
    Ling, Ching-Hsien
    Chau, Gar-Yang
    Hsia, Chen-Yuan
    King, Kuang-Liang
    HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1142 - 1147
  • [37] Hepatic iron concentration in tumor and non-tumor tissue in patients with end-stage liver disease and hepatocellular carcinoma.
    Tung, BY
    Teicher, HB
    Emond, MJ
    Bronner, MP
    Taylor, SL
    Kowdley, KV
    HEPATOLOGY, 1999, 30 (04) : 282A - 282A
  • [38] Predicting Morbidity and Mortality After Hepatic Resection in Patients with Hepatocellular Carcinoma: The Role of Model for End-Stage Liver Disease Score
    Hsu, Kuang-Yu
    Chau, Gar-Yang
    Lui, Wing-Yiu
    Tsay, Shyh-Haw
    King, Kuang-Liang
    Wu, Chew-Wun
    WORLD JOURNAL OF SURGERY, 2009, 33 (11) : 2412 - 2419
  • [39] Predicting Morbidity and Mortality After Hepatic Resection in Patients with Hepatocellular Carcinoma: The Role of Model for End-Stage Liver Disease Score
    Kuang-Yu Hsu
    Gar-Yang Chau
    Wing-Yiu Lui
    Shyh-Haw Tsay
    Kuang-Liang King
    Chew-Wun Wu
    World Journal of Surgery, 2009, 33 : 2412 - 2419
  • [40] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era Discussion
    Hemming, Alan W.
    Johnson, Lynt
    O'Leary, Pat
    Perry, Roger
    Stain, Steven C.
    Levi, David M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 735 - 736
12345